User profiles for A. Seyfoddin
Ali SeyfoddinProfessor of Biopharmaceutics , School of Science, Faculty oh Verified email at aut.ac.nz Cited by 2637 |
Solid lipid nanoparticles for ocular drug delivery
A Seyfoddin, J Shaw, R Al-Kassas - Drug delivery, 2010 - Taylor & Francis
Ocular drug delivery remains challenging because of the complex nature and structure of
the eye. Conventional systems, such as eye drops and ointments, are inefficient, whereas …
the eye. Conventional systems, such as eye drops and ointments, are inefficient, whereas …
[HTML][HTML] Nanoantioxidants: Recent trends in antioxidant delivery applications
…, SM Dezfooli, NBM Julkapli, WJ Basirun, A Seyfoddin - Antioxidants, 2019 - mdpi.com
Antioxidants interact with free radicals, terminating the adverse chain reactions and converting
them to harmless products. Antioxidants thus minimize the oxidative stress and play a …
them to harmless products. Antioxidants thus minimize the oxidative stress and play a …
Ophthalmic gels: Past, present and future
AA Al-Kinani, G Zidan, N Elsaid, A Seyfoddin… - Advanced drug delivery …, 2018 - Elsevier
Aqueous gels formulated using hydrophilic polymers (hydrogels) along with those based on
stimuli responsive polymers (in situ gelling or gel forming systems) continue to attract …
stimuli responsive polymers (in situ gelling or gel forming systems) continue to attract …
Application of fused deposition modelling (FDM) method of 3D printing in drug delivery
Three-dimensional (3D) printing is an emerging manufacturing technology for biomedical
and pharmaceutical applications. Fused deposition modelling (FDM) is a low cost extrusion-…
and pharmaceutical applications. Fused deposition modelling (FDM) is a low cost extrusion-…
Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems
…, A Aghaei Afshar, A Seyfoddin - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including autoimmune
diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19. However…
diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19. However…
Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants
Non-oral long-acting drug delivery systems (LADDS) encompass a range of technologies
for precisely delivering drug molecules into target tissues either through the systemic …
for precisely delivering drug molecules into target tissues either through the systemic …
A 3D printed chitosan-pectin hydrogel wound dressing for lidocaine hydrochloride delivery
A chitosan-pectin (CS-PEC) biopolymeric hydrogel wound dressing was investigated for
lidocaine delivery. Here we demonstrate for the first time the feasibility of three-dimensional (3D…
lidocaine delivery. Here we demonstrate for the first time the feasibility of three-dimensional (3D…
Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir
A Seyfoddin, R Al-Kassas - Drug development and industrial …, 2013 - Taylor & Francis
The objective of the present investigation was to improve the ocular bioavailability of acyclovir
by incorporating it into solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (…
by incorporating it into solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (…
Acrylic acid/acrylamide based hydrogels and its properties-A review
…, M Mostakhdemin, LK Dkhar, A Seyfoddin… - Polymer Degradation …, 2020 - Elsevier
Hydrogels are among the well-liked biomaterials due to their biocompatibility and non-toxic
properties which can be used in various applications in the field of engineering and medicine…
properties which can be used in various applications in the field of engineering and medicine…
Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems
MN Yasin, D Svirskis, A Seyfoddin… - Journal of Controlled …, 2014 - Elsevier
Efficient drug delivery to the posterior segment of the eye is a challenging task for the
formulation scientist. Current treatment of chronic back-of-the-eye conditions requires frequent …
formulation scientist. Current treatment of chronic back-of-the-eye conditions requires frequent …